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Mijnheer de rector magnificus,
Dear friends and colleagues, ladies and gentlemen.
To say farewell means to remember. For this reason I will dedicate this farewell lecture
not primarily to the latest developments of my research discipline but to talk about
my experiments and experiences as a Dutch professor with a German passport over
the last 23 years at Leiden University and in The Netherlands. Not to talk primarily
about research in the field of drug delivery is due to the fact that many of you have
attended my farewell symposium during the last two days where excellent speakers
have given you the state of the art of this area. However, I will give you my views
about the future of drug therapy and drug delivery later on in this lecture.
Because many of you are not so familiar with the Dutch language, I got the permis-
sion from the rector magnificus to give this lecture in the English language. When I
invited my old Dutch language teacher, professor Cor Soeteman (and here I can really
say old, because he is with his 91 years certainly the oldest guest of today) to this
symposium and informed him that I will give my farewell lecture in English, he
immediately replied that this is excellent because in this case he has not to correct my
Dutch manuscript. You may think that this is not a real compliment about my knowl-
edge of the Dutch language even after 23 years. I only can tell you that the Dutch lan-
guage is a very difficult one. Just recently there was in the radio news a comment that
around 75% of the native Dutchmen have problems to use their own language cor-
rectly. Anyhow, he was my Dutch language teacher and I visited him in the beginning
of my stay in Leiden every week with my prepared lessons. I learned not only Dutch
but also I was informed about the history and traditions of Leiden University at the
highest level, because professor Soeteman was also rector magnificus of Leiden
University in 1970/71. Pay unit was a bottle of (preferentially German) white wine. At
that time it was a little problem to get all the bottles into The Netherlands, because
the European Union was still far from being reality and hence the import of wine was
restricted to 2 liters per person and checks at the border have been routinely per-
formed.
Although I have never been a real champion in languages I felt that I made some
progress relatively quickly. Arriving during the first years from one of my many trav-
els at Leiden railway station and taking a taxi back home or to the department, the
taxi drivers supposed after some conversation that I am not a Dutch. In the very
beginning they thought I am Belgian, then they moved me over the border to the
Netherlands and thought I would come from Limburg and later even from Brabant.
To my personal regret, I was never recognized as a Leiden citizen. In general, the real
breakthrough in commanding a language is, when you go to the market, give your
orderings in Dutch and the reply is not German any more but really in Dutch. Then
you made it! The same holds if you pick up the phone and you immediately under-
stand the message that is given to you phonetically. And even better if you have not to
ask your neighbors anymore when your young children come home with words
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which you doubt that they belong to the vocabulary they should use. But in summary,
learning the Dutch language so quickly gave me a lot of credit of my colleagues.
Just some remarks about Leiden University traditions: when you are appointed as
professor here in Leiden you have to give your inaugural lecture. In former times you
did not get paid by the university before you did not have done so, but this rule fortu-
nately has been abolished due to the long waiting list to get a date. For instance, I
gave my inaugural lecture 14 months after being appointed. For your inaugural lec-
ture you have to wear under your new gown, called toga, a tail and it is basically the
only chance as normal professor to get admitted to talk from the higher pulpit behind
me. For the farewell lecture you have to use the lower pulpit and you can decide
either to wear a normal suit or as I did to again wear the toga together with my col-
leagues from Leiden and also from other universities. I must admit that I always was
very proud to wear my Leiden toga on many occasions.
Originally, I was appointed as professor for pharmaceutical technology and dispens-
ing, because at that time Leiden University still had a school of pharmacy. It was also
expected that I would continue the research in tabletting as has been performed by
my predecessor, professor Ko Polderman. He is also here today and it is certainly a
real privilege to welcome him here today. But back to the experiments: two very sim-
ple tabletting experiments with magnesium stearate and lactose powders, one mixed
for 1 min and the other milled for 1 hour showed me, that I could better change to
another research area, because both compression experiments showed the same force-
displacement curves. But the physical results were quite different: whereas the gently
mixed powder resulted in a hard tablet, the “deadly mixed one” remained more or less
a powder or very soft tablet when ejected from the die. To my opinion – even having
one of the best equipped and calibrated tabletting machines at my hands in my new
department – the experiments clearly showed the limitations of force-displacement
measurements in powder compaction at that time.
Hence after these crucial experimental results I decided  to start in Leiden with the
research area of colloidal structures of ointments and creams on which I had already
worked in Braunschweig as well together with professor Claus Führer. Also the first
Ph.D. theses done in Leiden covered this area which later has been greatly extended
by the late Harry Boddé. Currently, Joke Bouwstra is focusing more and more also on
the biophysics of the skin and modern transdermal drug delivery. Most of the money
I got after my appointment to establish my research was used to buy a Kratky camera
with a position sensitive detector and the Balzers freeze etching apparatus. Whereas
the first is replaced today by synchroton techniques, the latter one is still in use.
With my German scientific background I was really surprised about the Dutch
research culture, open and international with all publications in the English language
and a strong interest in mutual collaboration. I always found and still feel this situa-
tion so unique that no offer could get me back to Germany or to another country.
And this open research culture certainly gives the Dutch universities an advantageous
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basis to continue with superior research especially in times when the money is scarce.
As everybody knows research in the life of a professor is one thing, but the rest is
spent on meetings. The Dutch magic word for this is “vergadering” and sometimes (at
least in the beginning) I got the impression that 50% of the academic staff were
attending a vergadering, whereas the other 50% could work. This statement especially
holds when you consider that many committees were busy to work out new strate-
gies, with the other 50% trying to implement these plans.
The 3rd task of a professor is to teach. It started with some difficulties for me when
giving my lectures in the Dutch language for the first time. On many occasions it
resulted in a lot of hilarity on the students’ side. Imagine you try to explain some-
thing and suddenly the students start to laugh and you don’t know why! Nevertheless,
the relationship with the students was always good and we had the gentleman’s agree-
ment that I will try to teach them in the best way the field of pharmaceutics, whereas
they corrected me when my writing at the blackboard contained errors.
A special experience was the Leiden student association “Aesculapius”, considering my
German background where such activities of students’ unions are still contaminated
with a “haut gout”. Many of the Aesculapius activities, such as symposia and excur-
sions to neighboring countries, are parts of our education system. In the last 23 years I
was helpful in the organization of such excursions and I participated with great pleas-
ure in at least 7 trips to other European countries. And several times when I attended
the Aesculapius meeting in which the old executive committee has to be formally dis-
charged and the new one inaugurated, I waited until around 2 or 3 o’clock in the
morning to finally effectuate the transition from the old executive boards to the new
ones. In 1996, I became honorary member of Aesculapius and I am very proud of this
honor. One of my colleagues told me: you may get a lot of scientific recognition but
the most precious one is to be recognized, by your students as a good teacher.
My most expensive car-wash was also a deal with Aesculapius. During the 1995
Aesculapius symposium, the organization had to use my brand new Mercedes car
because somebody forgot to bring a bouquet of flowers with him and they urgently
needed a car to pick up the flowers on time. This was the first time that my new car
was not driven by myself. Additionally, Aesculapius had also some financial problems.
I donated 500 Dutch guilders and as a compensation for this donation and borrowing
my car the Aesculapius board promised to wash it. It was not a real success story for
me: when the students finally washed my car in front of the Gorlaeus Laboratories,
two of my colleagues who did not know about the deal, accused me of exploiting the
students in a way which was already history at Dutch universities for many years.
In 1984, just 3 years after my appointment in Leiden, the Dutch Government decided
to close 2 of the 4 subfaculties of pharmacy, namely Amsterdam and Leiden. My fam-
ily and me already made plans for the worst-case scenario to return to Germany.
Fortunately our pharmacy school in Leiden was allowed to re-organize to a research
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center called firstly Center for Bio-Pharmaceutical Sciences. Douwe Breimer played
the leading role in this. All departments got the unique chance to reorganize them-
selves in the best way to become one of the leading research divisions in the world.
When the chemistry divisions of the Vrije Universiteit Amsterdam joined us and the
Leiden/Amsterdam Center for Drug Research was formed, a Research School was
established, unique in the world and very successful both in research and teaching
undergraduate and graduate students. I was and I am still very proud to be part of
this Center. Probably my most prominent non-scientific contribution to this
Graduate School was to name it Leiden/Amsterdam Center for Drug Research (abbre-
viated LACDR) and not Leiden/Amsterdam Institute for Drug Research, because the
abbreviation LAIDR, although spelled differently in German, would mean “unfortu-
nately” and this was to be avoided.
Scientifically LACDR performed really very well. Just about 8 months ago the evalua-
tion of all departments by an international peer panel resulted in marks between very
good and excellent, marks other research units in the world dream about. Since its
inception this was the third peer review of the LACDR and all of them contributed to
the improvement of the Center’s performance.
In contrast to e.g. Germany, the basic teaching load at LACDR is and was very low.
When I told my German colleagues that I have to lecture 12 hours they always asked
“in one week, what a heavy task?” and when I said “no” the following question was “in
one month?” And again the answer was “no”. They normally could not believe that it
was the teaching load for one year. Some of my foreign colleagues may have got the
impression that our education system was very poor and especially in the beginning I
often heard the question with a pitiful undertone “How long you still have to stay in
the Netherlands?” and my answer to this question was always that I love to stay here.
Why? Because this Dutch university system is much more flexible and effective in
education and research than in other countries.
Teaching undergraduates and graduates the latest research developments and not to
be bound onto a catalogue of sometimes boring topics which have to be lectured, I
really felt the freedom of teaching pharmaceutical sciences and enjoyed my small
teaching load with the clear direction to make the best of it.
To not leave you with a wrong impression that 12 hours were the total teaching load in
the division of pharmaceutics, the total number was much higher because I had to share
it with my colleagues in the department, but it was still moderate in comparison to other
countries. Without any doubt, also the evaluation of the teachers by the students in the
presence of the study advisor improved the teaching quality and most of the critical
remarks of the students were implemented and improved the quality of teaching.
I often thought about this teaching load and questioned myself whether my students
are worse educated than other students. My answer to this question was always “no”,
because I believe that the Dutch teaching culture at universities is different from
other countries. Here in The Netherlands the pupils are already trained at secondary
school before joining the university to learn and study much more independently.
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Although their real knowledge of facts may be less than that of other students, their
better training of conceptual thinking to solve problems makes them much more
flexible and suitable in a changing world where knowledge doubles in about every ten
years or less.
A university is not an ivory tower in which you do research, you also have to commu-
nicate with the outside world. We knew when we moved from Germany to the
Netherlands in 1981, that the Dutch sympathy for Germans was still very restricted.
Furthermore, many Germans visiting the Netherlands did and still do not know a lot
about the second world war and post second world war history of the Netherlands.
This fact also may create a lot of problems and does not increase the sympathy for
Germany. I still appreciate the unique attitude of our neighbors in Rijnsburg where
we lived when the first time the 4th and 5th May were celebrated. The 4th May is to
remember all those who have died during the Second World War and the 5th May is
the feast to celebrate the liberation from the Germans. Our neighbors came to us in
the evening of 4th May and explained to us their historical perspective of the situation
and emphasized that this has nothing to do with us personally. This helped us a lot to
understand the Dutch feelings.
Another key experience in the very beginning of my stay in Leiden for me was the
conversation with an old man with two crutches, whom I picked up with my car at
the highway just outside of Leiden when I drove back to Germany. He told me that he
was forced to work for the Nazis when the Netherlands were occupied, but that he
could run away, was then captured again and was brought to Dachau. At Christmas’
eve in 1943 a drunken Nazi broke his arm and legs with an iron pole. He survived,
but since that time he was handicapped and unable to have a normal life. He was
from Soest and came to Leiden to get new crutches. When I brought him to his home
in Soest he thanked me and told me that he had since many years no bad feelings
against the Germans anymore. I prayed that this was really true.
As a fact I had never a clash with somebody because of my German nationality inside
and outside the university, although sometimes people told me the difference between
friends and neighbors: your friend you can choose, your neighbor not.
In 1989 when the German re-unification became a fact, the anti German feelings in
the Netherlands again increased. Political Den Haag was against the re-unification
and the fear of a strong Germany was also felt very strongly among the population of
this country. When it culminated, I watched a Dutch TV program in which it was
reported that a female teacher for 6 years old children was fearing that the Nazis
would come back to gas all the children. Germany was lucky to have at this time the
best ambassador here in The Hague, namely Otto von der Gablentz (whom I had the
privilege to know personally very well) and who was also a good friend of the late
Prince Claus of the Netherlands (a German as well) and it is certainly their merit that
the waves have been smoothed and finally the German re-unification was also accept-
ed in the Netherlands.
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In 1995 on the occasion of the 50th anniversary of the end of World War II, Queen
Beatrix gave her famous speech encouraging her fellow countrymen to reconcile with
their neighbors in the East. Since that time the relationship between both countries
improved, also strongly supported by writers as e.g. Tessa de Loo. In her book “The
Twins” (de tweeling), two originally Dutch sisters have been separated just before the
beginning of the second world war and been brought to relatives both in Germany
and the Netherlands. After the war they lost contact and met many years later by acci-
dent in the place Spa in Belgium. With a lot of empathy the author tells the stories of
both sisters and the initial non-understanding of the situation during and after the
war both in the Netherlands and in Germany and at the end the mutual understand-
ing by the twins of the German and the Dutch situation. The movie made in The
Netherlands from this twin story was just chosen some weeks ago as the best Dutch
movie of 2003 with the motivation that this movie also attracts the elderly Dutch
population. This fact also gives hope for a better understanding between both
nations.
I also sincerely hope that the next Clingendael Report, the Dutch Institute of foreign
relationships, will come to a better result of how the Dutch junior citizens estimate
their neighboring countries. In the report from 1997, Germany was still at the end of
the scale of popularity, although the great majority of the kids interviewed never have
been to Germany before. There is certainly still a latent unpopularity of Germany and
this should be changed by more goodwill not only when the Dutch team plays foot-
ball or soccer against the Mannschaft of Germany. H.W. von der Donk characterizes
football games between these two countries as “continuation of the war with friendly
tools”, especially enforced by the fact that Germany won in 1974 the soccer world cup
against Holland. I do hope that this Dutch trauma of Munich will become past histo-
ry in the near future.
You may understand that there are many good reasons why I spent some time on this
topic: one of my main goals here in the Netherlands was always to be also a good
ambassador for Germany and if I have succeeded to be one, I will be very glad and
satisfied. Fortunately, I am not a good football player!
Back to the LACDR. Besides performing good research and a good teaching program
for undergraduates and Ph.D. students, the third mission of the Center is to also col-
laborate with the pharmaceutical industry. For a department of Pharmaceutics and
Drug Delivery this was never a problem. When I recall the situation  around 1980 in
Germany at that time correctly, collaboration with industry was something unethical
you should not do. Why? Because you must be aware that your freedom of research
could be jeopardized due to the binding restrictions of the contracts with the indus-
try. Leiden University and LACDR facilitated industrial collaboration from the very
beginning in a really professional way. There was always a liaison officer with a
responsibility of the contracts and at least in the beginning a committee which
checked the scientific merits of the industrial project. As a result of this we never per-
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formed routine research for pharmaceutical companies, we always worked for mutual
scientific benefits. The resulting philosophy was to use the Ph.D. positions from the
first money stream paid by the university for basic research and to check with the
industrial projects the fundamentals in the industrial practice. We always have been
good partners to the pharmaceutical industry. I will illustrate this with only one
example. In 1982 we started collaboration with the Schwarz company and continued
for 20 years without interruption until today where still two projects are going on.
And many other research projects with industry partners around the world followed
and have been successful as well.
My certainly most exotic collaboration started in June 1984 when two gentlemen
from Aruba, one of the Dutch Antilles islands, visited me here in Leiden. Honestly
speaking at that time I did not know what Aruba was and means. The gentlemen
wanted me to help them to develop cosmetic products based on aloe vera which is
wild growing on the island. After a long beating about the bush I finally agreed to
come to Aruba, a decision which lightened the burden of the two gentlemen very
much and which was the start to a still existing and very fruitful and successful col-
laboration. At the end of my academic career I can say that I have developed more
than 80 cosmetic products which are really on the market for sale and which are sold
with great success on the Caribbean island and within the United States. The market
chances in the Netherlands still have to be explored. The products are continuously
updated under very severe quality control conditions comparable to those of the
pharmaceutical industry for which I am responsible. As a consequence I went at least
since 1984 once per year to Aruba, a fact which certainly was the basis for my today’s
nickname  “Flying Dutchman”!
To summarize this chapter in Leiden, I think we are one of the most successful divi-
sions if not the most successful one of LACDR with regard to collaboration with the
pharmaceutical industry.
Another situation which gave me enormous freedom to get also involved in other
duties was the fact that all departments have two regular assistant or associate profes-
sor positions. If you fill them in with excellent researchers (and I was happy to always
succeed in this) you also have some time available to serve scientific organizations
without neglecting your Ph.D. students and your industrial projects.
In the autumn of 1985 I was asked to become the president of APV (Association for
Pharmaceutical Technology) and to additionally organize the next APV Congress in
Leiden. The date was planned in the middle of April 1986 when the tulips normally
are in full bloom. However, the winter before was so cold that at the congress only the
leaves of the tulips were out of the ground but no flowers. In my introductory remarks
to the congress I showed some pictures of how it should look like when square miles
of the ground in the neighborhood of Leiden are in red, yellow and pink colors.
Only later I recognized the influence of flowers on the memory of participants at a
congress. Many years later a lady told me that she still remembered the Leiden APV
congress quite well, not the scientific lectures and posters but my tulip slides. This is
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another reason why this lecture today is not a predominantly scientific one, because
in this case you would forget it very quickly as well! 
During this congress I was elected APV president without having been before on the
Executive Board of the society. The next years were quite tough and I was faced with
almost bankruptcy of APV due to the investment in a wrong computer fed with more
or less useless information. My Board helped me a lot in this time and after 4 years
when I left APV as president the society was again financially sound. The only thing I
regret is that my Board did not go with me to organize the 1990 APV congress in
Dresden in the former German Democratic Republic. After the re-unification of
Germany it would have been the first congress organized there.
In 1994 I was elected president of the Controlled Release Society, an American based
international society. During that time I learned a lot about managing the club.
Although the American system is quite efficient in getting a new officer worked in
during the term as vice president and president-elect, the only one year period as
president is too short to be really effective within such a structured organization and
most decisions are taken by the general manager.
The last example. In September 1993 I was invited by my dear colleague Daan
Crommelin to give a lecture during the FIP Congress in Tokyo in Japan. With pleas-
ure, I accepted this invitation to have a chance to visit this fascinating country.
However, I did not anticipate the real purpose of this invitation. Daan at that time
was Scientific Secretary of FIP, the International Pharmaceutical Federation. During
the Gala dinner I was approached by my good friend Kamal Midha, Chairman of the
Board of Pharmaceutical Sciences, whether I would be interested in becoming the
successor of Daan as Scientific Secretary of FIP in 1995. This was also the reason for
this invitation! I accepted to become the 4th Scientific Secretary in a famous row start-
ing with my predecessor Ko Polderman, continued by Douwe Breimer and Daan
Crommelin. Just two months ago I finished my second term having then served 8
years for FIP, primarily representing the scientists around the world within FIP. With
also having the new and 5th Scientific Secretary attending this lecture, namely Dr.
Vinod Shah from FDA, we certainly have nearly 40 years of FIP history today in this
venerable building of Leiden University!
Because representatives from all societies for which I served are here today, I cannot
have done a too bad job. But most of you know that I can be very to the point, tough
and thus not always easy to handle, but at the end of my scientific career I have
learned a lot of diplomacy and we have solved most of our problems in an amicable
way. Serving all these societies over the years my maxim always was that the society
has the highest priority before my own benefit.
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“To love what you do and feel that it matters – how could anything be more fun?” To
my opinion this citation of Katherine Graham describes very well the work of a uni-
versity professor. I liked my work very much. I never could understand when people
said that they are happy to close the door of their working place behind them and go
for 3 weeks of holidays. I never had these feelings. I really loved my work. To spend
many hours during the weekends at the department was never wasted time.
Walt Disney once said: it is a special kind of fun to do the impossible, and I agree
with this. To do the impossible started when Harry Boddé and Joke Bouwstra
matured so far in their skin and transdermal delivery systems research that they need-
ed no further help from me. Although not a very smoothly going process, I finally
decided to look for another research topic. The newly chosen topic was to try to make
the mucosal delivery of peptides and proteins and their absorption feasible. You have
heard in the last two days some of our achievements presented by my own co-work-
ers and in all modesty I think we have made some progress especially on the
approaches of mucosal immunization, where my remaining Ph.D. students have suc-
cessfully worked on and are still working on. In retrospective also the second change
of a research topic was a good decision following the motto: if you can dream it, you
can do it!
After the successful decoding of the human genome pharmaceutical sciences have
entered a new era with a lot of expected break-through in the future. As the computer
has revolutionized our daily life in the last years in a really unexpected way, the post
genomic era will do the same in an even more radical way both in terms of diagnos-
tics and therapeutics. Basically it must be easy: you only need zero and one in your
computer and the 4 DNA bases and life can be decoded by what we today call “bioin-
formatics”. Whether it is really so easy or only one of the many hypes we already have
passed, remains to be determined. I have never heard in the last years about so many
paradigm shifts in research and completely new insights that I do hope that our
descendants in 50 years are of the same opinion about the real impact of our current
scientific work. Whatever will be the truth, it is hoped that it will be only for the ben-
efit of mankind.
At the end of your scientific career at Leiden University you will question yourself:
What did you and we achieve in the last 20 years in drug delivery? Which progress
did we make? I think the honest answer is disappointing: we still do not have delivery
systems on the market which are able to deliver the drug “on demand” for optimal
drug therapy avoiding toxic side effects. We still do not have so-called “closed-loop
systems” or “feed-back systems” to achieve this goal. But we certainly have been able
to show the way how to go further on, what are the merits of safe polymeric penetra-
tion enhancers, what type of delivery systems have to be designed to make oral pep-
tide absorption feasible. And even more advanced: the transdermal intophoretic
approach with potent drugs to treat the Parkinson disease could also be used to
measure even not kinetic effects, but also to measure disease parameters as stiffness of
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the Parkinson patient or the shaking frequency of his hands. This really will allow
optimal drug therapy “on-demand”. The chip technology has matured so far in the
meantime that the external measurements of such disease parameters became already
feasible.
But will such sophisticated delivery systems be further developed by the pharmaceuti-
cal industry? I doubt. In a time of economic depression and strong and unpopular
cuts in the health care systems in most countries such systems will not be affordable
in the years to come. If we believe the gurus in the next 10 years, more than 80 % of
all drugs will still be administered as conventional dosage forms for oral delivery and
only a few percent will belong to the class of novel sophisticated systems.
To my opinion the post genomic era will focus more on the direction of individual-
ized drug therapy. After having decoded all our personal genome patterns, we will
among other information know whether we are normal, poor or hyper metabolizers
of a certain drug with as a positive result an optimized drug therapy. I do not believe
that completely individualized drug therapy will become reality soon - if at all -  due
to the immense costs which would be involved to achieve real personalized drug ther-
apy. Also the health care providers and health care politics in more general terms will
not like to see us getting too old. In the future there will be an increasing gap between
what will be feasible in both optimized drug therapy and drug delivery and on the
other side what can we afford to pay.
Many of you here may already have had the same feelings that just after having finished
his or her Ph.D. thesis the topic became really interesting. The same holds if you decide
to retire and you will finish your scientific career: now the research especially in the
field of vaccine research and delivery is really becoming exciting. I do hope that we will
have soon more genetically engineered potent vaccines suitable for mucosal delivery.
Nevertheless, we have to stop at one point. I decided to go with early retirement after
having had so far an exceptional life. However, all my successes never would have
become reality without my staff members, Ph.D. students, technicians and postdocs. I
especially would like to thank Joke Bouwstra, Coos Verhoef and Gerrit Borchard for
their support and collaboration over many years.
At this moment I personally feel like being a medicine, the shelf-life of which has now
expired, but in which 97% of the active ingredient are still intact. I do not call myself
to rest from this hobby called science, but would like to continue with the remaining
intact brain in other interesting fields at other universities, and I do sincerely hope
that you all will stay in contact with me and remain in my near in the years to come.
Ik heb gezegd.
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